VBI Vaccines, Inc. – Ordinary Shares (VBIV) Reaches $4.96 After 9.00% Up Move; 7 Analysts Bullish Genesee & Wyoming (GWR)

July 17, 2017 - By Adrian Erickson

The stock of VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) is a huge mover today! About 110,946 shares traded. VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) has risen 7.87% since July 17, 2016 and is uptrending. It has underperformed by 8.83% the S&P500.The move comes after 8 months positive chart setup for the $195.50 million company. It was reported on Jul, 17 by Barchart.com. We have $5.41 PT which if reached, will make NASDAQ:VBIV worth $17.60M more.

Among 11 analysts covering Genesee & Wyoming Inc. (NYSE:GWR), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. Genesee & Wyoming Inc. had 29 analyst reports since August 5, 2015 according to SRatingsIntel. The company was upgraded on Monday, November 2 by Macquarie Research. The stock of Genesee & Wyoming Inc (NYSE:GWR) earned “Outperform” rating by Cowen & Co on Tuesday, August 4. The company was downgraded on Tuesday, February 23 by Morgan Stanley. Deutsche Bank maintained Genesee & Wyoming Inc (NYSE:GWR) on Monday, October 12 with “Buy” rating. Cowen & Co maintained the stock with “Buy” rating in Monday, July 10 report. The company was maintained on Wednesday, April 12 by RBC Capital Markets. The firm earned “Outperform” rating on Monday, December 14 by Stephens. The stock of Genesee & Wyoming Inc (NYSE:GWR) has “Outperform” rating given on Thursday, February 9 by Cowen & Co. The rating was maintained by Citigroup on Friday, April 29 with “Buy”. Bank of America downgraded Genesee & Wyoming Inc (NYSE:GWR) on Friday, September 11 to “Neutral” rating. See Genesee & Wyoming Inc (NYSE:GWR) latest ratings:

10/07/2017 Broker: Cowen & Co Rating: Buy New Target: $75.0000 Maintain
06/07/2017 Broker: RBC Capital Markets Rating: Hold New Target: $67.0000 Maintain
22/06/2017 Broker: Credit Suisse Rating: Buy New Target: $77.0000
03/05/2017 Broker: Cowen & Co Rating: Outperform Old Target: $77.00 New Target: $75.00 Maintain
19/04/2017 Broker: Bank of America Old Rating: Neutral New Rating: Buy New Target: $76.00 Upgrade
12/04/2017 Broker: RBC Capital Markets Rating: Hold Maintain
09/02/2017 Broker: Cowen & Co Rating: Outperform Old Target: $72 New Target: $77 Maintain

Among 2 analysts covering VBI Vaccines (NASDAQ:VBIV), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. VBI Vaccines had 2 analyst reports since July 26, 2016 according to SRatingsIntel. On Tuesday, July 26 the stock rating was initiated by Ladenburg Thalmann with “Buy”. As per Monday, October 10, the company rating was initiated by Laidlaw.

Analysts await VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) to report earnings on August, 21. They expect $-0.17 EPS, up 26.09% or $0.06 from last year’s $-0.23 per share. After $-0.22 actual EPS reported by VBI Vaccines, Inc. – Ordinary Shares for the previous quarter, Wall Street now forecasts -22.73% EPS growth.

Genesee & Wyoming Inc. owns and operates freight railroads across the world. The company has market cap of $4.27 billion. As of December 31, 2016, the Company owned or leased 122 freight railroads worldwide that are organized in 10 operating regions. It has a 28.71 P/E ratio. The Firm operates through three divisions, which include North American Operations, Australian Operations and U.K./European Operations.

Investors sentiment increased to 1.89 in 2016 Q4. Its up 0.72, from 1.17 in 2016Q3. It improved, as 14 investors sold Genesee & Wyoming Inc shares while 75 reduced holdings. 55 funds opened positions while 113 raised stakes. 58.36 million shares or 5.62% more from 55.25 million shares in 2016Q3 were reported. Teacher Retirement System Of Texas invested in 4,495 shares or 0% of the stock. Glenmede Trust Na invested in 122 shares. Washington Tru Financial Bank has invested 0% in Genesee & Wyoming Inc (NYSE:GWR). Price T Rowe Assoc Md owns 1.19M shares. Castleark Mngmt owns 184,615 shares for 0.41% of their portfolio. Blackrock Fund invested 0.03% in Genesee & Wyoming Inc (NYSE:GWR). Alyeska Invest Grp L P reported 549,809 shares. Bluecrest Mngmt Ltd reported 143,559 shares. Millennium Mgmt Llc owns 177,617 shares for 0.03% of their portfolio. Eulav Asset stated it has 0.1% of its portfolio in Genesee & Wyoming Inc (NYSE:GWR). First Wilshire Securities Mngmt Incorporated invested in 3,350 shares or 0.07% of the stock. Blackrock Advsr Limited Liability Company invested in 0.01% or 178,650 shares. Stephens Ar invested in 7,745 shares or 0.02% of the stock. 800 were accumulated by Ancora Limited Co. Piermont Capital Management Inc, Missouri-based fund reported 19,838 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.